South Africa, the worst affected country on the continent, delayed an initial vaccination plan using the AstraZeneca vaccine due to concerns about its efficacy against a new variant of coronavirus.
It started vaccinating on 17 February after receiving 80,000 doses of the Johnson & Johnson vaccine, which is administered as a single dose and has been shown to be effective against the variant.
Pfizer has also committed to supply 20 million vaccine doses, with deliveries expected by the end of March.
South Africa has offered the one million doses of the AstraZeneca vaccine it ordered from the Indian supplier to the African Union, to distribute to other countries which might be interested in using it.
This piece was originally published on 20 February 2021, but is updated regularly to include the latest information.